Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 6.4.1.4 extracted from

  • Eminoglu, F.T.; Ozcelik, A.A.; Okur, I.; Tumer, L.; Biberoglu, G.; Demir, E.; Hasanoglu, A.; Baumgartner, M.R.
    3-Methylcrotonyl-CoA carboxylase deficiency: phenotypic variability in a family (2009), J. Child Neurol., 24, 478-481.
    View publication on PubMed

Application

Application Comment Organism
medicine study of a family with 3-methylcrotonyl-CoA carboxylase deficiency with different clinical features. The three patients display elevated urinary 3-hydroxyisovaleric acid and 3-methylcrotonylglycine, elevated 3-hydroxyisovalerylcarnitine and decreased free carnitine levels. Methylcrotonyl-CoA carboxylase activity in cultured fibroblasts displays a low residual activity of 2.2% of the median control value while propionyl-CoA carboxylase activity is normal in the index patient. Mutation analysis reveals a large homozygous deletion of 2264 bp, i.e. c.873รพ4524_6787de12264 in the subunit MCCA gene Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
family with 3-methylcrotonyl-CoA carboxylase deficiency
-